2 million antibody products . Find yours today
View products

2 matching Fc Fragment Of IgE Receptor II antibodies for Peptide ELISA from 31 suppliers

Superstar Kits

Fc Fragment Of IgE Receptor II information

Aliases

Fc Fragment Of IgE Receptor II is also known as BLAST-2, CD23, CD23A, CLEC4J, Fc-epsilon-RII, FCE2, FCER2, Fcer2a, FceRII, IGEBF, Lymphocyte IgE receptor, sCD23

1 Applications, 4 Species currently selected


View matching ELISA Kits

2 matching Fc Fragment Of IgE Receptor II antibodies for Peptide ELISA after applying filters

Click each Fc Fragment Of IgE Receptor II antibody that interests you to view the full Fc Fragment Of IgE Receptor II antibody datasheet.
View only Fc Fragment Of IgE Receptor II Monoclonal Antibodies or Fc Fragment Of IgE Receptor II Polyclonal Antibodies
Biorbyt

Fc Fragment Of IgE Receptor II antibodies


orb469379 Rabbit Anti-Fc Fragment Of IgE Receptor II antibody, Polyclonal, HRP
100 ug Hu, Mo, Rt
IHC-P, Pep-ELISA, WB
Datasheet

Related antibodies

Fc Fragment Of IgE Receptor II antibodies are often published withAssociated citations
CD1942.6%
Complement C3d Receptor 234.8%
CD11b20.6%
CD5 Molecule17.7%
CD93 Molecule13.5%
CD812.8%
CD4512.1%
CD2012.1%
CD11C10.6%
CD22 Molecule8.5%

Featured Research

anti-Fc Fragment Of IgE Receptor II Antibody
101612 (BioLegend)
Mo  / FACS
doi:
anti-Fc Fragment Of IgE Receptor II Antibody
406509 (BioLegend)
Mo  / FACS
doi:
anti-Fc Fragment Of IgE Receptor II Antibody
505818 (BioLegend)
Mo  / ELISA
doi:
anti-Fc Fragment Of IgE Receptor II Antibody
101618 (BioLegend)
Mo  / FACS
doi:
anti-Fc Fragment Of IgE Receptor II Antibody
338514 (BioLegend)
Hu  / FACS
doi:10.1165/rcmb.2013-0112OC
anti-Fc Fragment Of IgE Receptor II Antibody
338513 (BioLegend)
Hu  / FACS
doi:10.1165/rcmb.2013-0112OC

Antibody Resource

Antibody Resource is the premier source of antibody and elisa products from the major suppliers.

Unit 3 The Bury, Newmarket Road, Stow-Cum-Quy, Cambridgeshire CB25 9AQ, United Kingdom

+44 1223 813746

antibody@antibodyresource.com

Copyright 1997-2024 Zing Ventures. All rights reserved

FIND US ON